AFIB Quote, Financials, Valuation and Earnings

Electromed, Inc. has a net margin of -19.72% compared to Acutus Medical, Inc.'s net margin of 12.65%. Acutus Medical, Inc.'s return on equity of -1790.4% beat Electromed, Inc.'s return on equity of 18.89%.

Acutus Medical, Inc. has a consensus price target of --, signalling upside risk potential of 249900%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 23.63%. Given that Acutus Medical, Inc. has higher upside potential than Electromed, Inc., analysts believe Acutus Medical, Inc. is more attractive than Electromed, Inc..

Acutus Medical, Inc. has a beta of -1.265, which suggesting that the stock is 226.527% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.266, suggesting its less volatile than the S&P 500 by 73.442%.

Acutus Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acutus Medical, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

Acutus Medical, Inc. quarterly revenues are $7.1M, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Acutus Medical, Inc.'s net income of -$1.4M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Acutus Medical, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 31.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acutus Medical, Inc. is 0.00x versus 3.88x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Myomo, Inc. has a net margin of -19.72% compared to Acutus Medical, Inc.'s net margin of -36.3%. Acutus Medical, Inc.'s return on equity of -1790.4% beat Myomo, Inc.'s return on equity of -68.35%.

Acutus Medical, Inc. has a consensus price target of --, signalling upside risk potential of 249900%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 449.45%. Given that Acutus Medical, Inc. has higher upside potential than Myomo, Inc., analysts believe Acutus Medical, Inc. is more attractive than Myomo, Inc..

Acutus Medical, Inc. has a beta of -1.265, which suggesting that the stock is 226.527% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.052, suggesting its more volatile than the S&P 500 by 5.158%.

Acutus Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acutus Medical, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.

Acutus Medical, Inc. quarterly revenues are $7.1M, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. Acutus Medical, Inc.'s net income of -$1.4M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Acutus Medical, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acutus Medical, Inc. is 0.00x versus 0.90x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -19.72% compared to Acutus Medical, Inc.'s net margin of -862.39%. Acutus Medical, Inc.'s return on equity of -1790.4% beat VolitionRX Ltd.'s return on equity of --.

Acutus Medical, Inc. has a consensus price target of --, signalling upside risk potential of 249900%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 760.72%. Given that Acutus Medical, Inc. has higher upside potential than VolitionRX Ltd., analysts believe Acutus Medical, Inc. is more attractive than VolitionRX Ltd..

Acutus Medical, Inc. has a beta of -1.265, which suggesting that the stock is 226.527% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.

Acutus Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acutus Medical, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Acutus Medical, Inc. quarterly revenues are $7.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Acutus Medical, Inc.'s net income of -$1.4M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Acutus Medical, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acutus Medical, Inc. is 0.00x versus 17.51x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -19.72% compared to Acutus Medical, Inc.'s net margin of 3.93%. Acutus Medical, Inc.'s return on equity of -1790.4% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Acutus Medical, Inc. has a consensus price target of --, signalling upside risk potential of 249900%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 91.33%. Given that Acutus Medical, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Acutus Medical, Inc. is more attractive than Xtant Medical Holdings, Inc..

Acutus Medical, Inc. has a beta of -1.265, which suggesting that the stock is 226.527% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

Acutus Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acutus Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Acutus Medical, Inc. quarterly revenues are $7.1M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Acutus Medical, Inc.'s net income of -$1.4M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Acutus Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acutus Medical, Inc. is 0.00x versus 0.86x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.